Adil Daud
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers 111
- CAR-T cell therapy research 87
- Cutaneous Melanoma Detection and Management 36
- Colorectal Cancer Treatments and Studies 21
- HER2/EGFR in Cancer Research 17
- Immunology top 0.2%
- Immunotherapy and Immune Responses 59
- Molecular Biology top 0.5%
- Melanoma and MAPK Pathways 96
- Histone Deacetylase Inhibitors Research 17
- Biotechnology top 0.5%
- Cancer Research top 1%
- Co-authors
- Omid HamidPamela N. MünsterAntoni RibasCaroline RobertDaniel M. SullivanAlain P. AlgaziKaty K. TsaiNageatte Ibrahim
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- Journal of Clinical Oncology (107 papers)Annals of Oncology (16 papers)Clinical Cancer Research (12 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Adil Daud
297 papers receiving 15.8k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 10.3k
- Immunology 5.2k
- Molecular Biology 7.4k
- Biotechnology 747
- Cancer Research 1.2k
Countries citing papers authored by Adil Daud
This map shows the geographic impact of Adil Daud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adil Daud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adil Daud more than expected).
Fields of papers citing papers by Adil Daud
This network shows the impact of papers produced by Adil Daud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adil Daud. The network helps show where Adil Daud may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adil Daud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 15 | |
| 7 | 2021 | 19 | |
| 8 | 2020 | 198 | |
| 9 | 2019 | 30 | |
| 10 | 2017 | 336 | |
| 11 | STUDI SANITASI RUMAH SAKIT IBNU SINA MAKASSAR DAN RUMAH SAKIT PELAMONIA MAKASSAR | 2015 | 0 |
| 12 | ANALISIS RISIKO ARSEN (As) DALAM IKAN KEMBUNG DAN KERANG DARAH DI WILAYAH PESISIR MAKASSAR | 2014 | 2 |
| 13 | IDENTIFIKASI RESIDU PESTISIDA KLORPIRIFOS DALAM SAYURAN KOL MENTAH DI PASAR TERONG KOTA MAKASSAR DAN SAYURAN KOL SIAP SANTAP DI KANTIN JASPER UNIVERSITAS HASANUDDIN MAKASSAR | 2014 | 1 |
| 14 | IDENTIFIKASI RESIDU PESTISIDA GOLONGAN ORGANOFOSFAT PADA SAYURAN KENTANG DI SWALAYAN LOTTEMART DAN PASAR TERONG KOTA MAKASSAR TAHUN 2013 | 2013 | 0 |
| 15 | 2011 | 68 | |
| 16 | 2009 | 78 | |
| 17 | Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanomabreakdown → | 2008 | 503 |
| 18 | 2008 | 146 | |
| 19 | IDENTIFIKASI RESIDU PESTISIDA KLORPIRIFOS DALAM CABAI BESAR DAN CABAI RAWIT DI PASAR TERONG DAN LOTTE MART KOTA MAKASSAR | 2008 | 1 |
| 20 | ANALISIS RISIKO PAPARAN KADMIUM (Cd) PADA AIR DAN KERANG PUTIH (ANADONTA WOODIANA) DI SUNGAI PANGKAJENE TAHUN 2012 | 2008 | 1 |
About Adil Daud
Adil Daud is a scholar working on Oncology, Immunology and Molecular Biology, having authored 315 papers that have together received 16.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (111 papers), Melanoma and MAPK Pathways (96 papers), CAR-T cell therapy research (87 papers), Immunotherapy and Immune Responses (59 papers), Cutaneous Melanoma Detection and Management (36 papers), Colorectal Cancer Treatments and Studies (21 papers), Histone Deacetylase Inhibitors Research (17 papers) and HER2/EGFR in Cancer Research (17 papers). The work is most often cited by research in Oncology (10.3k citations), Immunology (5.2k citations) and Molecular Biology (7.4k citations). Adil Daud has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Omid Hamid, Pamela N. Münster, Antoni Ribas, Caroline Robert, Daniel M. Sullivan, Alain P. Algazi, Katy K. Tsai, Nageatte Ibrahim, Douglas C. Marchion and Jeffrey S. Weber. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, European Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.